Nitric oxide: a pro-inflammatory mediator in lung disease?

Authors:
van der Vliet A; Eiserich JP; Cross CE.

Journal:
Respir Res

Publication Year: 2000

DOI:
10.1186/rr14

PMCID:
PMC59543

PMID:
11667967

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Respir Res

Abbreviation: Respir Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A combination of mild-moderate hypoxemia and low compliance is highly prevalent in persistent ARDS:…
Papoutsi E; Andrianopoulos I; Mavrikaki V and 8 more (2024) - Transparency Score: 3/6
Advancing accuracy in breath testing for lung cancer: strategies for improving diagnostic precision…
Chen KC; Kuo SW; Shie RH and 1 more (2024) - Transparency Score: 3/6
Associations between long-term ozone exposure and small airways function in Chinese young adults: a…
Feng S; Yang L; Dou S and 10 more (2024) - Transparency Score: 3/6
Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomiz…
Eltahan NH; Elsawy NH; Abdelaaty KM and 3 more (2024) - Transparency Score: 4/6
Bhlhe40 deficiency attenuates LPS-induced acute lung injury through preventing macrophage pyroptosi…
Hu X; Zou M; Zheng W and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"AcknowledgementsWe thank NIH (HL57432 and HL60812), the University of California Tobacco-Related Disease Research Program (7RT0167), and the American Heart Association for research support."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025